AssetMark Inc
TMO icon

AssetMark Inc’s Thermo Fisher Scientific TMO Stock Holding History

AssetMark Inc’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.4M Buy
66,520
+7,779
+13% +$3.73M 0.06% 255
2026
Q1 		$28.9M Buy
58,741
+21,087
+56% +$11.4M 0.06% 253
2025
Q4 		$21.8M Buy
37,654
+7,023
+23% +$3.97M 0.04% 306
2025
Q3 		$14.9M Buy
30,631
+7,400
+32% +$3.44M 0.03% 362
2025
Q2 		$9.42M Sell
23,231
-14,832
-39% -$6.2M 0.02% 420
2025
Q1 		$18.9M Buy
38,063
+163
+0.4% +$88.3K 0.05% 253
2024
Q4 		$19.7M Buy
37,900
+1,979
+6% +$1.09M 0.05% 249
2024
Q3 		$22.2M Sell
35,921
-1,198
-3% -$709K 0.06% 219
2024
Q2 		$20.5M Buy
37,119
+6,152
+20% +$3.52M 0.06% 222
2024
Q1 		$18M Buy
30,967
+3,001
+11% +$1.68M 0.06% 225
2023
Q4 		$14.8M Buy
27,966
+2,802
+11% +$1.36M 0.05% 230
2023
Q3 		$12.7M Buy
25,164
+2,546
+11% +$1.36M 0.05% 232
2023
Q2 		$11.8M Buy
22,618
+2,378
+12% +$1.28M 0.05% 237
2023
Q1 		$11.7M Buy
20,240
+1,764
+10% +$994K 0.05% 223
2022
Q4 		$10.2M Buy
18,476
+1,890
+11% +$1M 0.04% 228
2022
Q3 		$8.41M Buy
16,586
+1,951
+13% +$1.09M 0.04% 229
2022
Q2 		$7.95M Buy
14,635
+5,335
+57% +$2.94M 0.04% 232
2022
Q1 		$5.49M Buy
9,300
+4,968
+115% +$2.85M 0.02% 257
2021
Q4 		$2.89M Buy
4,332
+2,751
+174% +$1.72M 0.01% 295
2021
Q3 		$903K Sell
1,581
-10,897
-87% -$5.98M ﹤0.01% 398
2021
Q2 		$6.29M Buy
12,478
+11,038
+767% +$5.21M 0.03% 257
2021
Q1 		$657K Sell
1,440
-86
-6% -$41K ﹤0.01% 413
2020
Q4 		$711K Sell
1,526
-189
-11% -$88.6K ﹤0.01% 388
2020
Q3 		$757K Buy
1,715
+12
+0.7% +$4.96K ﹤0.01% 363
2020
Q2 		$617K Sell
1,703
-2,587
-60% -$867K ﹤0.01% 363
2020
Q1 		$1.22M Buy
4,290
+1,734
+68% +$547K 0.01% 300
2019
Q4 		$830K Buy
2,556
+23
+0.9% +$6.97K 0.01% 363
2019
Q3 		$738K Buy
2,533
+10
+0.4% +$2.86K 0.01% 340
2019
Q2 		$741K Sell
2,523
-88
-3% -$24.2K 0.01% 320
2019
Q1 		$715K Sell
2,611
-404
-13% -$101K 0.01% 312
2018
Q4 		$675K Sell
3,015
-165
-5% -$38.7K 0.01% 309
2018
Q3 		$776K Sell
3,180
-46
-1% -$10.6K 0.01% 321
2018
Q2 		$668K Sell
3,226
-174
-5% -$36.9K 0.01% 324
2018
Q1 		$702K Sell
3,400
-269
-7% -$56.5K 0.01% 318
2017
Q4 		$697K Sell
3,669
-289
-7% -$55.4K 0.01% 325
2017
Q3 		$749K Buy
3,958
+230
+6% +$41.7K 0.01% 317
2017
Q2 		$650K Sell
3,728
-943
-20% -$158K 0.01% 320
2017
Q1 		$717K Sell
4,671
-22
-0.5% -$3.36K 0.01% 308
2016
Q4 		$662K Sell
4,693
-247
-5% -$36.4K 0.01% 302
2016
Q3 		$786K Buy
4,940
+102
+2% +$15.7K 0.01% 271
2016
Q2 		$715K Sell
4,838
-2,534
-34% -$374K 0.01% 293
2016
Q1 		$1.04M Sell
7,372
-123
-2% -$16.5K 0.02% 263
2015
Q4 		$1.06M Buy
7,495
+6,896
+1,151% +$920K 0.02% 268
2015
Q3 		$73K Buy
599
+407
+212% +$53K ﹤0.01% 366
2015
Q2 		$25K Buy
+192
New +$25K ﹤0.01% 450

Other funds holding TMO

Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

AssetMark Inc's TMO Position: Q2 2026 in Review

AssetMark Inc increased its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, buying an estimated $3.73M and bringing the position to 66,520 shares worth $33.4M. The position accounts for 0.06% of the portfolio, ranked #255.

AssetMark Inc first reported a position in TMO in Q2 2015 and has held it in 45 quarters since. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • AssetMark Inc held 66,520 shares of Thermo Fisher Scientific worth $33.4M as of Q2 2026.
  • AssetMark Inc bought 7,779 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.73M.
  • Thermo Fisher Scientific made up 0.06% of AssetMark Inc's portfolio in Q2 2026, its #255 holding.
  • AssetMark Inc first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 45 quarters since.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.